Updated Guidelines on Outpatient Anticoagulation | AAFP
Bridging the Gap: How to Transition from the NOACs to Warfarin - PDF Free Download
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism | Thrombosis Journal | Full Text
Xarelto® - Responsible Use
Rivaroxaban: a fully-subsidised oral anticoagulant
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar - ScienceDirect
Guidance on converting between anticoagulants
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
![PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c3bd71fdf61b8f8bdc9321c5d380254016ae03ea/20-Table1-1.png "PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar")
PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar
Oral anticoagulants in the management of venous thromboembolism | Nature Reviews Cardiology
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Anticoagulants | Health Navigator NZ
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Apixaban starting dose after 1 week LMWH therapy (PE or DVT)? | ResearchGate
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials -
Treatment Considerations | XARELTO® (rivaroxaban) HCP
Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) - PDF Free Download
Cureus | Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
